SOX2 and cancer: Further involving SOX2 in cancer stemness, elevated SOX2 expression associates with chemotherapy-resistance effects [52], induces stemness and endothelial-to-mesenchymal-transition gene signatures [17], and promotes clonogenicity and in vivo tumorigenicity in respective model systems [43, 52].